Stalfort John A III
- SEC CIK
- 0001709418
No open-market purchases or sales filed in the past year.
Current role at each company
- ABOS Acumen Pharmaceuticals, Inc.Directoras of Jun 5, 2026
- TSHA Taysha Gene Therapies, Inc.Directoras of Jun 2, 2026
- VRCA Verrica Pharmaceuticals Inc.Directoras of Nov 26, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Stalfort John A III as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VRCA Verrica Pharmaceuticals Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 26, 2024 (view filing) | Nov 22 | 4 days | Stalfort John A IIIDirector | PPurchase | +1.12M | – | – | +160.5%1.82M after | |
| Nov 26, 2024 (view filing) | Nov 22 | 4 days | Stalfort John A IIIDirector | PPurchase | +1.12M | – | – | –561.8K after | Derivative2 lots |
| Jul 5, 2022 (view filing) | Jul 5 | Same day | Stalfort John A IIIDirector | PPurchase | +238.1K | $2.10 | +$500.0K | +51.5%700.2K after |
TSHA Taysha Gene Therapies, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2023 (view filing) | Aug 16 | Same day | Stalfort John A IIIDirector | PPurchase | +388.9K | $0.90 | +$350.0K | +78.5%884.3K after | |
| Aug 16, 2023 (view filing) | Aug 16 | Same day | Stalfort John A IIIDirector | PPurchase | +388.9K | $0.90 | +$350.0K | +63.7%999.4K after |
ABOS Acumen Pharmaceuticals, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 8, 2021 (view filing) | Jul 6 | 2 days | Stalfort John A IIIDirector | PPurchase | +35.0K | $16.00 | +$560.0K | +25.5%172.3K after |